Monoclonal antibodies in multiple sclerosis treatment: current and future steps

Monoclonal antibodies in multiple sclerosis treatment: current and future steps

Bibliographic Details
Main Authors:	Claire L. Helliwell, Alasdair J. Coles
Format:	Article
Language:	English
Published:	SAGE Publishing 2009-07-01
Series:	Therapeutic Advances in Neurological Disorders
Online Access:	https://doi.org/10.1177/1756285609337827

Similar Items

Monoclonal Antibodies in Multiple Sclerosis: Present and Future
by: Natalia V. Voge, et al.
Published: (2019-03-01)

Monoclonal Antibodies for Multiple Sclerosis Treatment
by: Filipe Palavra
Published: (2015-09-01)

MONOCLONAL ANTIBODY FOR MULTIPLE SCLEROSIS TREATMENT
by: E. V. Popova
Published: (2017-05-01)

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.
by: Coles, A, et al.
Published: (1999)

Monoclonal antibodies in development in multiple sclerosis
by: J. Sastre-Garriga, et al.
Published: (2011-11-01)

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis.
by: Coles, A, et al.
Published: (1999)

Newer therapies for multiple sclerosis
by: Alasdair Coles
Published: (2015-01-01)

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.
by: Coles, A, et al.
Published: (2006)

Monoclonal Antibodies: Present and Future in the Treatment of Multiple Sclerosis (Based on the Proceedings of the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis - ECTRIMS)
by: Marina V. Votintseva, et al.
Published: (2017-08-01)

Multiple Sclerosis: Current Knowledge of the Pathology and Use of Monoclonal Antibodies as a Promising Therapy
by: Josué Castellón-Arias, et al.
Published: (2023-11-01)

Monoclonal antibodies in the treatment of multiple sclerosis: from clinical research to practical application
by: N. Yu. Lashch
Published: (2020-07-01)

Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review
by: Elsbernd PM, et al.
Published: (2021-06-01)

Systematic review of gender bias in clinical trials of monoclonal antibodies for the treatment of multiple sclerosis
by: M. Alonso-Moreno, et al.
Published: (2023-11-01)

Systematic review of gender bias in clinical trials of monoclonal antibodies for the treatment of multiple sclerosis
by: M. Alonso-Moreno, et al.
Published: (2023-11-01)

Monoclonal antibodies in neurology: current state and future development
by: Maria N. Zakharova
Published: (2018-12-01)

Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review
by: D. L. Klabukova, et al.
Published: (2018-11-01)

Use of monoclonal antibodies in patients with multiple sclerosis in the practice of a neurologist
by: N. Yu. Lashch
Published: (2020-03-01)

Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes
by: Jan Lycke
Published: (2015-11-01)

Monoclonal Antibodies for Chronic Pain Treatment: Present and Future
by: Eva M. Sánchez-Robles, et al.
Published: (2021-09-01)

Current and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphoma
by: Suheil Albert Atallah-Yunes, et al.
Published: (2022-01-01)

Current and Future Biomarkers in Multiple Sclerosis
by: Jennifer Yang, et al.
Published: (2022-05-01)

Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects
by: Jiwon Oh, et al.
Published: (2014-09-01)

The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis
by: Martin Diebold, et al.
Published: (2019-03-01)

Cutaneous Adverse Reactions Associated with Monoclonal Antibodies Treatment in Multiple Sclerosis: Case Reports and Short Literature Review
by: Carmen Adella Sirbu, et al.
Published: (2022-06-01)

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
by: Grzegorz Kardas, et al.
Published: (2022-12-01)

Relevance of Pathogenetic Mechanisms to Clinical Effectiveness of B-Cell-Depleting Monoclonal Antibodies in Multiple Sclerosis
by: Luca Massacesi, et al.
Published: (2022-07-01)

Monoclonal Antibodies in Pregnancy and Breastfeeding in Patients with Multiple Sclerosis: A Review and an Updated Clinical Guide
by: Panagiotis Gklinos, et al.
Published: (2023-05-01)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
by: Jakub Radocha, et al.
Published: (2021-03-01)

Review of cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments
by: Rao Khalid Mehmood
Published: (2014-09-01)

The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment
by: Stephen L. Hauser, et al.
Published: (2023-07-01)

Anti CD38 monoclonal antibodies for multiple myeloma treatment
by: Alessandro Gozzetti, et al.
Published: (2022-11-01)

Current trends in monoclonal antibody development and manufacturing /
by: Shire, Steven J.
Published: (2010)

Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives
by: Eugenia Quiros-Roldan, et al.
Published: (2021-12-01)

The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects
by: Per Soelberg Sorensen, et al.
Published: (2016-01-01)

Monoclonal antibodies for organ transplantation: prospects for the future.
by: Waldmann, H
Published: (1988)

Future directions in cancer immunotherapy with monoclonal antibodies
by: Lucía Cabello-Alemán
Published: (2022-12-01)

Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging
by: Brian Effer, et al.
Published: (2023-07-01)

Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment
by: Sonia Morè, et al.
Published: (2020-11-01)

Therapeutic Monoclonal Antibodies against Cancer: Present and Future
by: Marisa Delgado, et al.
Published: (2023-12-01)

Monoclonal Antibodies in Dermatooncology—State of the Art and Future Perspectives
by: Malgorzata Bobrowicz, et al.
Published: (2019-09-01)